Invezz

Not just SoundHound, these AI stocks are also riding Nvidia wave

  • Nvidia's 13F filing shows investments in AI firms such as SoundHound AI, Arm, Nanox Imaging, and Recursion.
  • SoundHound AI's shares have dramatically increased, tripling in value.
  • Shares of Nanox Imaging have soared, driven by its groundbreaking digital X-ray source tech.

Following Nvidia's investment disclosure, SoundHound AI's shares have dramatically increased, tripling in value and boosting its market capitalization to $2.75 billion.

The company's success is attributed to its innovative AI voice technology used across various industries, from fast-food to automotive.

A recent earnings report showed an 80% revenue jump, prompting analysts to raise their price targets significantly.

Nvidia's AI investments

Nvidia's 13F filing revealed its investments in several AI-centric companies, including SoundHound AI, Arm, Nanox Imaging, and Recursion Pharmaceuticals, all of which have seen their stock prices climb.

Nvidia's investment strategy underscores the chipmaker's commitment to advancing AI technology across multiple sectors.

Arm see growth amid AI boom

Arm's shares have seen a modest increase since Nvidia's investment disclosure.

The company, known for its semiconductor designs, has reported record-high revenue thanks to the AI boom, with its technology becoming increasingly indispensable in AI applications.

Nanox Imaging's health tech surge

Shares of Nanox Imaging have soared, driven by its groundbreaking digital X-ray source technology and AI-driven solutions for early disease detection.

The company's vision for accessible and preventative healthcare has resonated with investors, reflected in its stock's impressive rise.

Recursion Pharmaceuticals' biotech jumps

Recursion Pharmaceuticals, another beneficiary of Nvidia's investments, has seen its shares grow significantly.

Despite a revenue dip, the company's innovative use of machine learning for drug discovery highlights the potential of AI in revolutionizing the biotech industry.